Nykredit A/S’s Amgen AMGN Stock Holding History

Nykredit A/S’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$49M	Buy	+135,233	New	+$46.3M	0.19%	103

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Nykredit A/S's AMGN Position: Q2 2026 in Review

Nykredit A/S opened a new position in Amgen (AMGN) in Q2 2026: 135,233 shares worth $49M. The stake represents 0.19% of the portfolio and ranks #103 among its holdings.

3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Nykredit A/S held 135,233 shares of Amgen worth $49M as of Q2 2026.
Amgen was a new Nykredit A/S position in Q2 2026.
Amgen made up 0.19% of Nykredit A/S's portfolio in Q2 2026, its #103 holding.
3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.